News

News
In the media

Johnson & Johnson: The Leading Healthcare Group at the Forefront of Open Innovation

Read full story
Other news

TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases

Read full story
Other news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
In the media

Michael Hübner – New Venture Lead, Johnson & Johnson Innovation Switzerland

Read full story
Other news

Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem

Read full story
Other news

entrinsic bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients

Read full story
Other news

Thirty Madison Raises $140 Million in Series C Financing Led by HealthQuest Capital

Read full story
In the media

BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs

Read full story
In the media

As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on

Read full story
In the media

Ethics should be a compulsory course for every science student

Read full story
In the media

Women Who Tech Launches Health Innovation Challenge

Read full story
Other news

Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38

Read full story
In the media

Pharma’s New R&D Models: Federating Innovation with Paul Stoffels M.D.

Read full story